Ayala Pharmaceuticals OTC Stock Forward View
| ADXS Stock | USD 0.57 0.01 1.79% |
Ayala OTC Stock outlook is based on your current time horizon.
The value of RSI of Ayala Pharmaceuticals' otc stock price is slightly above 64. This suggests that the otc stock is rather overbought by investors at this time. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Ayala, making its price go up or down. Momentum 64
Buy Extended
Oversold | Overbought |
It is a matter of debate whether otc price prediction based on information in financial news can generate signals. We use our internally-built news screening methodology to estimate the value of Ayala Pharmaceuticals based on different types of headlines from major news networks to social media. Using Ayala Pharmaceuticals hype-based prediction, you can estimate the value of Ayala Pharmaceuticals from the perspective of Ayala Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Ayala Pharmaceuticals on the next trading day is expected to be 0.56 with a mean absolute deviation of 0.04 and the sum of the absolute errors of 2.57. Ayala Pharmaceuticals after-hype prediction price | USD 0.57 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as otc price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Ayala |
Ayala Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Ayala price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Ayala using various technical indicators. When you analyze Ayala charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Ayala Pharmaceuticals Naive Prediction Price Forecast For the 4th of February
Given 90 days horizon, the Naive Prediction forecasted value of Ayala Pharmaceuticals on the next trading day is expected to be 0.56 with a mean absolute deviation of 0.04, mean absolute percentage error of 0, and the sum of the absolute errors of 2.57.Please note that although there have been many attempts to predict Ayala OTC Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Ayala Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Ayala Pharmaceuticals OTC Stock Forecast Pattern
| Backtest Ayala Pharmaceuticals | Ayala Pharmaceuticals Price Prediction | Research Analysis |
Ayala Pharmaceuticals Forecasted Value
In the context of forecasting Ayala Pharmaceuticals' OTC Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Ayala Pharmaceuticals' downside and upside margins for the forecasting period are 0.01 and 94.92, respectively. We have considered Ayala Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Ayala Pharmaceuticals otc stock data series using in forecasting. Note that when a statistical model is used to represent Ayala Pharmaceuticals otc stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 112.5355 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0421 |
| MAPE | Mean absolute percentage error | 0.3877 |
| SAE | Sum of the absolute errors | 2.567 |
Predictive Modules for Ayala Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Ayala Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ayala Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Ayala Pharmaceuticals After-Hype Price Density Analysis
As far as predicting the price of Ayala Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Ayala Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of OTC Stock prices, such as prices of Ayala Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Ayala Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Ayala Pharmaceuticals' otc stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Ayala Pharmaceuticals' historical news coverage. Ayala Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.03 and 79.07, respectively. We have considered Ayala Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Ayala Pharmaceuticals is out of control at this time. Analysis and calculation of next after-hype price of Ayala Pharmaceuticals is based on 3 months time horizon.
Ayala Pharmaceuticals OTC Stock Price Outlook Analysis
Have you ever been surprised when a price of a OTC Stock such as Ayala Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Ayala Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the OTC price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Ayala Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
21.56 | 94.36 | 0.00 | 1.62 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.57 | 0.57 | 0.00 |
|
Ayala Pharmaceuticals Hype Timeline
Ayala Pharmaceuticals is presently traded for 0.57. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -1.62. Ayala is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is presently at 21.56%. %. The volatility of related hype on Ayala Pharmaceuticals is about 125813.33%, with the expected price after the next announcement by competition of -1.05. The company recorded a loss per share of 0.33. Ayala Pharmaceuticals had not issued any dividends in recent years. The entity had 1:125 split on the 29th of March 2019. Given the investment horizon of 90 days the next anticipated press release will be in 5 to 10 days. Check out Historical Fundamental Analysis of Ayala Pharmaceuticals to cross-verify your projections.Ayala Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Ayala Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Ayala Pharmaceuticals' future price movements. Getting to know how Ayala Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Ayala Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| HESG | Health Sciences Gr | (0.75) | 3 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| APLIF | Appili Therapeutics | 0.00 | 0 per month | 6.88 | (0.0009) | 20.00 | (16.67) | 42.48 | |
| AGNPF | Algernon Pharmaceuticals | 0.00 | 0 per month | 0.00 | (0.04) | 14.10 | (13.67) | 31.25 | |
| NMLSF | Nova Mentis Life | 0.00 | 0 per month | 5.98 | 0.09 | 16.00 | (13.81) | 66.40 | |
| RNUGF | ReNeuron Group Plc | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| AAGH | America Great Health | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| VGLS | Vg Life Sciences | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| IBOGF | Universal Ibogaine | 0.00 | 0 per month | 18.47 | 0.09 | 38.00 | (29.69) | 105.56 | |
| RGBP | Regen BioPharma | 0.00 | 0 per month | 0.00 | (0.07) | 20.00 | (17.00) | 63.57 | |
| AGTX | Agentix Corp | 0.00 | 0 per month | 3.94 | 0.01 | 2.04 | (6.38) | 49.60 |
Other Forecasting Options for Ayala Pharmaceuticals
For every potential investor in Ayala, whether a beginner or expert, Ayala Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Ayala OTC Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Ayala. Basic forecasting techniques help filter out the noise by identifying Ayala Pharmaceuticals' price trends.Ayala Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ayala Pharmaceuticals otc stock to make a market-neutral strategy. Peer analysis of Ayala Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Ayala Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Ayala Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Ayala Pharmaceuticals otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Ayala Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Ayala Pharmaceuticals otc stock market strength indicators, traders can identify Ayala Pharmaceuticals entry and exit signals to maximize returns.
Ayala Pharmaceuticals Risk Indicators
The analysis of Ayala Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Ayala Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting ayala otc stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 45.28 | |||
| Semi Deviation | 22.97 | |||
| Standard Deviation | 91.92 | |||
| Variance | 8449.83 | |||
| Downside Variance | 2555.68 | |||
| Semi Variance | 527.56 | |||
| Expected Short fall | (98.98) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Ayala Pharmaceuticals
The number of cover stories for Ayala Pharmaceuticals depends on current market conditions and Ayala Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Ayala Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Ayala Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Ayala Pharmaceuticals Short Properties
Ayala Pharmaceuticals' future price predictability will typically decrease when Ayala Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Ayala Pharmaceuticals often depends not only on the future outlook of the potential Ayala Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ayala Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Shares Percent Shares Out | 2.19% | |
| Short Percent Of Float | 2.19% | |
| Float Shares | 1.82M | |
| Shares Short Prior Month | 44.99k | |
| Average Daily Volume Last 10 Day | 1.63k | |
| Average Daily Volume In Three Month | 2.98k | |
| Date Short Interest | 15th of December 2021 |
Additional Tools for Ayala OTC Stock Analysis
When running Ayala Pharmaceuticals' price analysis, check to measure Ayala Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ayala Pharmaceuticals is operating at the current time. Most of Ayala Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Ayala Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ayala Pharmaceuticals' price. Additionally, you may evaluate how the addition of Ayala Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.